Qumas

About Qumas

Qumas, established in 1991 in Cork, Ireland, provides enterprise compliance management software solutions tailored for highly regulated industries, with a primary focus on the life sciences sector. The company was founded with Kevin O'Leary as a key founding member, who later became CEO in 2007. O'Leary, with a background in Computer Science and Industrial Management, was integral to the design of the company's first product and steered its growth, including its expansion into the United States in the 1990s. A significant milestone in the company's history was its acquisition by Accelrys in December 2013 for approximately $50 million. Subsequently, in 2014, Dassault Systèmes acquired Accelrys and integrated its activities to create the new brand, BIOVIA, which now includes the Qumas portfolio.

The firm's core business revolves around providing a comprehensive, cloud-based Quality Management System (QMS) that helps pharmaceutical, biotech, and medical device companies adhere to stringent global regulations, such as those from the FDA, EMA, and PMDA. Revenue is generated through the sale of its software, which can be deployed on-premises or in the cloud. The BIOVIA QUMAS platform offers an integrated suite of tools for managing the entire quality and compliance lifecycle. This includes the QUMAS EDMS (Electronic Document Management System) for content management and the QUMAS EQMS (Enterprise Quality Management System) for process management. Key features of the platform include document control, automated audit management, change control, deviation tracking, and management of Corrective and Preventive Actions (CAPA). The system ensures data integrity through electronic signatures and comprehensive audit trails, which are compliant with regulations like FDA 21 CFR Part 11. By centralizing all compliance-related content and processes into a single interface, the platform reduces the need for multiple point solutions, streamlines operations, and improves audit readiness.